According to Dr. Jeremy Burton, we’re in a golden age of microbiome and probiotics research.
“Thanks to advancements in next-generation sequencing, we’re learning more and more every day about the impacts of the microbiome on the human body,” states Dr. Burton.
From left: Cheryl Litchfield (Manager, Research Administration, Lawson) and Janet Knechtel (Senior Quality Assurance and Education Officer, Lawson)
One challenge of the COVID-19 pandemic has been the coordination of monitoring visits with clinical research study sponsors. Research institutes and sponsors across the province have had to explore alternate means for monitoring in alignment with public health directives. Normally performed in-person, monitoring visits help ensure that clinical trials are being conducted in a responsible manner and in accordance with sponsor requirements.